88 related articles for article (PubMed ID: 20629262)
1. FDA notifications. Updated Atripla label approved.
AIDS Alert; 2010 Mar; 25(3):36. PubMed ID: 20629262
[No Abstract] [Full Text] [Related]
2. [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
Warpakowski A
MMW Fortschr Med; 2009 Apr; 151(18):54-5. PubMed ID: 19769077
[No Abstract] [Full Text] [Related]
3. European CHMP issues positive opinion for Atripla.
AIDS Patient Care STDS; 2007 Nov; 21(11):890. PubMed ID: 18338431
[No Abstract] [Full Text] [Related]
4. Study shows people can safely switch to Atripla.
Proj Inf Perspect; 2008 Dec; (47):2. PubMed ID: 19226673
[No Abstract] [Full Text] [Related]
5. [Complete HAART in a single pill. New milestone for improving compliance].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():40-1. PubMed ID: 19024916
[No Abstract] [Full Text] [Related]
6. A controlled trial of initial antiviral regimens for HIV-1 infection.
Parienti JJ
N Engl J Med; 2010 Mar; 362(9):854; author reply 855. PubMed ID: 20200393
[No Abstract] [Full Text] [Related]
7. [One pill--all HAART. Complete divergent HAART in a single tablet per day].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():76-7. PubMed ID: 19024926
[No Abstract] [Full Text] [Related]
8. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
9. [Medication change due to side effects or possible long-term complications. Side effect management with vision].
Sankawa Y
MMW Fortschr Med; 2009 Apr; 151(18):35. PubMed ID: 19769072
[No Abstract] [Full Text] [Related]
10. The art of managing human immunodeficiency virus infection: a balancing act.
Reiss P
Clin Infect Dis; 2009 Nov; 49(10):1602-4. PubMed ID: 19842978
[No Abstract] [Full Text] [Related]
11. European Commission approves Atripla.
AIDS Patient Care STDS; 2008 Jan; 22(1):87-8. PubMed ID: 18453042
[No Abstract] [Full Text] [Related]
12. First of a kind in HIV treatment.
FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
[TBL] [Abstract][Full Text] [Related]
13. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
14. Oral preexposure prophylaxis for HIV--another arrow in the quiver?
Michael NL
N Engl J Med; 2010 Dec; 363(27):2663-5. PubMed ID: 21091280
[No Abstract] [Full Text] [Related]
15. Disseminated bartonellosis presenting as neuroretinitis in a young adult with human immunodeficiency virus infection.
Dutta A; Schwarzwald HL; Edwards MS
Pediatr Infect Dis J; 2010 Jul; 29(7):675-7. PubMed ID: 20216243
[TBL] [Abstract][Full Text] [Related]
16. [Simply convincing. New fixed combination for HIV therapy].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
[No Abstract] [Full Text] [Related]
17. 96-week CASTLE data show similar efficacy results.
AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
[No Abstract] [Full Text] [Related]
18. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
19. Vaccine briefs.
McEnery R; Kresge KJ
IAVI Rep; 2010; 14(6):18-9. PubMed ID: 21384772
[No Abstract] [Full Text] [Related]
20. Early end for FEM-PrEP HIV prevention trial.
AIDS Patient Care STDS; 2011 Jun; 25(6):383. PubMed ID: 21612547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
